Cardiovascular Risks Added To The Dangers Of Chantix
May 22, 2012
In addition to the risks of aggressive behavior and suicidal thoughts when taking the smoking cessation drug, Chantix, the U.S. Food and Drug Administration (FDA) has also stated that the medication could lead to cardiovascular complications. According to the FDA, patients who suffer from cardiovascular disease are the most at-risk of suffering adverse effects.
The warning was made after a study was conducted with 700 patients taking Chantix who suffered from cardiovascular disease. After one year, the drug was successful in helping patients stop smoking; however, patients taking Chantix were more likely to suffer heart attacks and other cardiovascular problems than patients who were taking placebos.
The FDA is continuing to investigate the link between Chantix and cardiovascular problems, but until then, the agency has stated that those patients suffering from cardiovascular disease should contact their doctor immediately if their symptoms worsen. This could include:
- Shortness of breath or trouble breathing
- New or worsening chest pain
- New or worsening pain in the legs when walking
The FDA also asks that patients report any adverse events related to Chantix immediately by utilizing the FDA MedWatch program.
Chantix dangers are numerous and may outweigh the benefits of taking the drug. That is why the St. Louis Drug Injury Lawyers with Cofman Townsley Injury Lawyers advise anyone experiencing abnormal effects while taking the drug to stop immediately and discuss the medication with your doctor.